May 2026
The global amyloid beta therapeutics market size was evaluated at USD 5.20 billion in 2025 and is predicted to hit around USD 26.50 billion by 2035, growing at a CAGR of 17.80%.
March 2025
The global amyloidosis therapeutics market size was valued at USD 2.94 billion in 2024 and is expected to hit around 6.45 billion by 2034, growing at a CAGR of 8.18% from 2025 to 2034.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
June 2026
The global Duchenne muscular dystrophy therapeutics market size was evaluated at USD 6.80 billion in 2025 and is predicted to hit around USD 26.88 billion by 2035, growing at a CAGR of 14.80%.
June 2026
The global breast cancer therapeutics market size was valued at USD 33.45 billion in 2025 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
June 2026
The global targeted therapeutics market size was estimated at USD 85.75 billion in 2025 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
June 2026
The global narcolepsy therapeutics market size is accounted at USD 4.12 billion in 2025 and is expected to hit around USD 9.31 billion by 2035 with a CAGR of 8.49%.
June 2026
The global THR-β agonist market size was evaluated at USD 1.53 billion in 2025 and is predicted to hit around USD 6.58 billion by 2035, growing at a CAGR of 15.72%.
May 2026
The global melanoma therapeutics market size accounted for USD 7.39 billion in 2025 and is expected to hit around USD 19.61 billion by 2035, at a CAGR of 10.25%.
May 2026
The global microbiome therapeutics market size is evaluated at USD 250.06 million in 2025 and is predicted to hit around USD 4,120.15 million by 2035, with a CAGR of 32.34%.
May 2026
The global multiple sclerosis therapeutics market size was evaluated at USD 34.80 billion in 2025 and is predicted to hit around USD 66.80 billion by 2035, growing at a CAGR of 6.90%.
May 2026
The global peptide therapeutics contract API manufacturing market size is estimated to hit around USD 9.02 billion by 2035 from USD 3.84 billion in 2025, at a CAGR of 9.02%.
May 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
May 2026
The mRNA therapeutics market size was valued at USD 20.83 billion in 2025 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
May 2026
The peptide therapeutics market size is expected to increase from USD 52.59 billion in 2025 to nearly USD 87.21 billion by 2035 with a notable CAGR of 5.19%.
May 2026
The global tau protein targeting therapeutics market size was evaluated at USD 1,100.00 million in 2025 and is predicted to hit around USD 6,534.16 million by 2035, growing at a CAGR of 19.50%.
April 2026
The global mRNA therapeutics CDMO market size is estimated to hit around USD 14.63 billion by 2035 from USD 5.09 billion in 2025, with a CAGR of 11.14%.
March 2026
The global pruritus therapeutics market size was valued at USD 11.74 billion in 2025 and is estimated to hit around USD 17.96 billion by 2035 with a CAGR of 4.34%.
March 2026
The global hospital infection therapeutics market size is projected to hit around USD 17.05 billion by 2035 from USD 12.82 billion in 2025 with a CAGR of 2.89%.
March 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
March 2026
The global allergy diagnostics and therapeutics market size is expected to hit around USD 75.07 billion by 2035 from USD 38.76 billion in 2025 with a CAGR of 6.83%.
February 2026
The global small interfering RNA (siRNA) therapeutics market size is estimated to hit around USD 528.78 billion by 2035 increasing from USD 193.95 billion in 2025, with a CAGR of 10.55%.
February 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.21 billion in 2025 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
February 2026
The global maternal health therapeutics market size was evaluated at USD 4.72 billion in 2025 and is predicted to hit around USD 9.64 billion by 2035, growing at a CAGR of 7.40%.
January 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.02 billion in 2025 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
January 2026
The global bispecific antibody therapeutics contract manufacturing market size was evaluated at USD 9.82 billion in 2025 and is predicted to hit around USD 218.92 billion by 2035, growing at a CAGR of 36.4%.
January 2026
The global digital therapeutics market size was exhibited at USD 9.73 billion in 2025 and is projected to surpass around USD 65.31 billion by 2035, with a remarkable CAGR of 20.97%.
January 2026
The pain management therapeutics market size accounted for USD 88.19 billion in 2025 and is predicted to hit around USD 127.78 billion by 2035, with a CAGR of 3.78%.
January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
January 2026
The global hepatitis therapeutics market size is calculated at USD 17.80 billion in 2025 and is projected to hit around USD 27.80 billion by 2035 with a CAGR of 4.56%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com